Search

everythinglearnresearchcommunity

for

Search:↓

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Genetic variants in CYP genes may worsen PCOS symptoms.

Hair RiseTM microemulsion effectively promotes hair growth and treats hair loss better than standard treatments.

Male pattern baldness does not cause an increased risk of prostate cancer.

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.

The document explains how male reproductive hormones work and affect the body.

Finasteride reduces prostate size and PSA levels in young patients.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

The document concludes that understanding health requires considering evolutionary perspectives on reproductive fitness, and recognizing the complexity of factors like diet, testosterone, and sexual orientation.

The models can help find better inhibitors for conditions like baldness and prostate disorders.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Testosterone therapy increases bone density in older men with low testosterone levels.

Finasteride doesn't harm male fertility or sperm quality, but may slightly reduce ejaculate volume.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

The guidelines aim to find treatable prostate cancer early while avoiding unnecessary tests and treatments.

New sulfur-containing steroid analogs show promise for more targeted medical treatments.

Mutations in certain receptors can cause diseases and offer new treatment options.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Metabolite 7 is a strong inhibitor for Alzheimer's disease management.

Case-only trees and random forests improve predictions of treatment effects in clinical trials.

Early hair loss may indicate future prostate issues.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.